612 related articles for article (PubMed ID: 28241431)
1. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
Iizuka K
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
[TBL] [Abstract][Full Text] [Related]
2. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.
Oh AR; Sohn S; Lee J; Park JM; Nam KT; Hahm KB; Kim YB; Lee HJ; Cha JY
Metabolism; 2018 Aug; 85():286-297. PubMed ID: 29669261
[TBL] [Abstract][Full Text] [Related]
3. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
Iizuka K; Horikawa Y
Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
[TBL] [Abstract][Full Text] [Related]
4. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.
Lee HJ; Cha JY
BMB Rep; 2018 Sep; 51(9):429-436. PubMed ID: 30158026
[TBL] [Abstract][Full Text] [Related]
5. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
6. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
7. ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption.
Kato T; Iizuka K; Takao K; Horikawa Y; Kitamura T; Takeda J
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534502
[TBL] [Abstract][Full Text] [Related]
8. Intestinal, but not hepatic, ChREBP is required for fructose tolerance.
Kim M; Astapova II; Flier SN; Hannou SA; Doridot L; Sargsyan A; Kou HH; Fowler AJ; Liang G; Herman MA
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263303
[TBL] [Abstract][Full Text] [Related]
9. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
10. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
Iizuka K
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
[TBL] [Abstract][Full Text] [Related]
12. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase.
Shi JH; Lu JY; Chen HY; Wei CC; Xu X; Li H; Bai Q; Xia FZ; Lam SM; Zhang H; Shi YN; Cao D; Chen L; Shui G; Yang X; Lu Y; Chen YX; Zhang WJ
Diabetes; 2020 Apr; 69(4):591-602. PubMed ID: 31974143
[TBL] [Abstract][Full Text] [Related]
13. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.
Zhang D; Tong X; VanDommelen K; Gupta N; Stamper K; Brady GF; Meng Z; Lin J; Rui L; Omary MB; Yin L
J Clin Invest; 2017 Jun; 127(7):2855-2867. PubMed ID: 28628040
[TBL] [Abstract][Full Text] [Related]
14. The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.
Agius L; Chachra SS; Ford BE
Front Endocrinol (Lausanne); 2020; 11():594041. PubMed ID: 33281747
[TBL] [Abstract][Full Text] [Related]
15. Recent Progress on Fructose Metabolism-Chrebp, Fructolysis, and Polyol Pathway.
Iizuka K
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049617
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
17. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
18. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
Shimada M; Hibino M; Takeshita A
Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
Ishii S; Iizuka K; Miller BC; Uyeda K
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F
Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
